Prognostic characterization of immune molecular subtypes in non-small cell lung cancer to immunotherapy

BACKGROUND: Non-small cell lung cancer (NSCLC) was usually associated with poor prognosis and invalid therapeutical response to immunotherapy due to biological heterogeneity. It is urgent to screen reliable biomarkers, especially immunotherapy-associated biomarkers, that can predict outcomes of thes...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chenlu, Pan, Jingjing, Luo, Jing, Chen, Xupeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628446/
https://www.ncbi.nlm.nih.gov/pubmed/34844602
http://dx.doi.org/10.1186/s12890-021-01765-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628446/
https://www.ncbi.nlm.nih.gov/pubmed/34844602
http://dx.doi.org/10.1186/s12890-021-01765-3

Ejemplares similares